MultiCenter, Randomized, Double-Blind study of Rozanolixizumab in Subjects with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
UCB Biopharma SPRL
Start Date
August 17, 2020
End Date
October 22, 2021
Administered By
Neurology, Neuromuscular Disease
Awarded By
UCB Biopharma SPRL
Start Date
August 17, 2020
End Date
October 22, 2021